Cas 1360880-37-0,5-(4-phenoxyphenyl)-5-(4-(2-nitrooxy-ethyl)piperazin-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione

1360880-37-0

Post Buying Request

Basic information

Product Name: 5-(4-phenoxyphenyl)-5-(4-(2-nitrooxy-ethyl)piperazin-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione
Synonyms:
CAS NO:1360880-37-0
Molecular Formula:
Molecular Weight: 469.454
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-(4-phenoxyphenyl)-5-(4-(2-nitrooxy-ethyl)piperazin-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione(CAS DataBase Reference)
NIST Chemistry Reference: 5-(4-phenoxyphenyl)-5-(4-(2-nitrooxy-ethyl)piperazin-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione(1360880-37-0)
EPA Substance Registry System: 5-(4-phenoxyphenyl)-5-(4-(2-nitrooxy-ethyl)piperazin-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione(1360880-37-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1360880-37-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1360880-37-0 Suppliers

Recommended suppliers

1360880-37-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1360880-37-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,0,8,8 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1360880-37:
(9*1)+(8*3)+(7*6)+(6*0)+(5*8)+(4*8)+(3*0)+(2*3)+(1*7)=160
160 % 10 = 0
So 1360880-37-0 is a valid CAS Registry Number.

1360880-37-0Upstream product

52808-35-2 1-(2-nitryloxy-ethyl)-piperazine

1360880-37-0Downstream Products

1360880-37-0Relevant academic research and scientific papers

Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion

Wang, Jun,O'Sullivan, Shane,Harmon, Shona,Keaveny, Ray,Radomski, Marek W.,Medina, Carlos,Gilmer, John F.

experimental part, p. 2154 - 2162 (2012/06/01)

We describe a new type of barbiturate-based matrix metalloproteinase (MMP) inhibitor incorporating a nitric oxide (NO) donor/mimetic group (series 1). The compounds were designed to inhibit MMP at enzyme level and to attenuate MMP-9 secretion arising from

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1360880-37-0